Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05234437
Title A Trial of Intratumoural Tigilanol Tiglate in Adult Participants With Stage IIIB to IV M1c Melanoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors QBiotics Group Limited
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
Melanoma Institute Australia Wollstonecraft New South Wales 2065 Australia Details
Cairns and Hinterland Hospital and Health Service Cairns Queensland 4870 Australia Details
Metro South Hospital and Health Service via Princess Alexandra Hospital Woolloongabba Queensland 4102 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field